|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
1
|
|
pubmed:dateCreated |
2009-1-9
|
|
pubmed:abstractText |
Guidelines recommend that for patients uncontrolled on inhaled corticosteroids (ICSs), step-up options include an increase in ICS dosage or addition of a long-acting beta-agonist (LABA). Controversy persists about the best option in routine practice.
|
|
pubmed:commentsCorrections |
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
AIM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Jan
|
|
pubmed:issn |
1097-6825
|
|
pubmed:author |
|
|
pubmed:issnType |
Electronic
|
|
pubmed:volume |
123
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
116-121.e10
|
|
pubmed:meshHeading |
pubmed-meshheading:18986690-Administration, Oral,
pubmed-meshheading:18986690-Adolescent,
pubmed-meshheading:18986690-Adrenal Cortex Hormones,
pubmed-meshheading:18986690-Adult,
pubmed-meshheading:18986690-Asthma,
pubmed-meshheading:18986690-Bronchodilator Agents,
pubmed-meshheading:18986690-Child,
pubmed-meshheading:18986690-Databases, Factual,
pubmed-meshheading:18986690-Female,
pubmed-meshheading:18986690-Follow-Up Studies,
pubmed-meshheading:18986690-Hospitalization,
pubmed-meshheading:18986690-Humans,
pubmed-meshheading:18986690-Male,
pubmed-meshheading:18986690-Middle Aged,
pubmed-meshheading:18986690-Models, Theoretical,
pubmed-meshheading:18986690-Regression Analysis,
pubmed-meshheading:18986690-Risk Factors
|
|
pubmed:year |
2009
|
|
pubmed:articleTitle |
High-dose inhaled corticosteroids versus add-on long-acting beta-agonists in asthma: an observational study.
|
|
pubmed:affiliation |
Department of General Practice and Primary Care, University of Aberdeen, Aberdeen, United Kingdom. mikethomas@doctors.org.uk
|
|
pubmed:publicationType |
Journal Article,
Comparative Study
|
